Mechanistically, RUNX1 promoted the chromatin accessibility and H3K4me3 modification via its interaction with NPM1 to enhance the transcriptional activation of FOSL2 towards ECM-related genes, resulting in the ECM remodeling and development of immunosuppressive microenvironment in GBM. The gene discussed is NPM1; the disease is glioblastoma.